Medication info
DayaB SMET Tablet 50/500 mg (Vildagliptin, Metformin Hydrochloride)

DayaB SMET Tablet 50/500 mg (Vildagliptin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Vildagliptin›50mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Korea Hutech Pharmaceutical Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202302279 · Approved 2023.07.28 · Insurance code 649105770

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding vildagliptin 100mg and metformin 2000mg. Doses of vildagliptin of 100mg or more per day are not recommended. This medicine should generally be taken with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no prior experience of antidiabetic drug therapy in whom adequate glycemic control is not achieved with monotherapy: The initial dose of this medicine is 1 tablet of 50/500mg once daily. The dose may be gradually increased to 1 tablet of 50/1000mg 2 times daily. 2. Patients switching from concomitant therapy with vildagliptin and metformin: Patients switching from concomitant therapy with vildagliptin and metformin to this medicine may start at their existing doses of vildagliptin and metformin. No studies have been conducted to evaluate the safety and efficacy of switching from other oral antidiabetic agents to this medicine. Any change in type 2 diabetes treatment may affect glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. If you miss a dose of this medicine, take it with your next meal unless it is time to take the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal before starting this medicine.

Ingredients

Manufacturer
Korea Hutech Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is prescribed to improve blood sugar control in patients with type 2 diabetes by using vildagliptin and metformin together, assisting in conjunction with dietary and exercise therapies. It effectively lowers blood glucose levels and is used to aid in the management of diabetes.

How to take

Adult dose

For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding vildagliptin 100mg and metformin 2000mg. Doses of vildagliptin of 100mg or more per day are not recommended. This medicine should generally be taken with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no prior experience of antidiabetic drug therapy in whom adequate glycemic control is not achieved with monotherapy: The initial dose of this medicine is 1 tablet of 50/500mg once daily. The dose may be gradually increased to 1 tablet of 50/1000mg 2 times daily. 2. Patients switching from concomitant therapy with vildagliptin and metformin: Patients switching from concomitant therapy with vildagliptin and metformin to this medicine may start at their existing doses of vildagliptin and metformin. No studies have been conducted to evaluate the safety and efficacy of switching from other oral antidiabetic agents to this medicine. Any change in type 2 diabetes treatment may affect glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. If you miss a dose of this medicine, take it with your next meal unless it is time to take the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal before starting this medicine.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia, so caution is necessary. It should especially not be used in patients with moderate to severe renal impairment, heart failure, acute cardiac conditions, or sepsis. If radiocontrast agents containing iodine are to be used for examination, this medication should be discontinued 48 hours prior to the examination, and it should only be resumed after confirming normal kidney function. It should not be administered to individuals with hypersensitivity to this medication or to patients with type 1 diabetes or diabetic ketoacidosis. In cases of severe infection, trauma, or around the time of surgery, this medication should be temporarily discontinued and resumed only after recovery of renal function. Caution is also advised in patients with liver dysfunction or excessive alcohol consumption, as well as those with severe gastrointestinal disorders. Pregnant or breastfeeding women should not take this medication. Irregular meals, intense exercise, and concurrent use of other medications can increase the risk of hypoglycemia or lactic acidosis, so careful usage is warranted. Symptoms such as headache, dizziness, nausea, and hypoglycemia may occur during treatment, and if these symptoms occur, consultation with healthcare professionals is essential. Regular blood tests are recommended to monitor kidney function in order to prevent renal impairment. Additionally, if acute pancreatitis symptoms appear, the medication should be discontinued immediately, and medical consultation should be sought. Alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid alcohol while taking this medication. Elderly patients or those with poor nutritional status are at a higher risk of hypoglycemia, hence extra caution is needed. In case of overdose, immediate medical attention should be sought, and dialysis may be necessary. This medication is not recommended for children and adolescents, and any skin abnormality should be reported to healthcare professionals promptly. Lastly, this medication does not replace insulin for patients needing insulin therapy, so it should be taken according to the healthcare provider's instructions.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • hepatitis
  • liver dysfunction
  • increased transaminase levels
  • angioedema
  • tremors
  • headache
  • dizziness
  • fatigue
Show 44 more
  • nausea
  • gastroesophageal reflux
  • diarrhea
  • bloating
  • chills
  • decreased blood sugar
  • asthenia
  • sweating
  • constipation
  • arthralgia
  • upper respiratory infection
  • pharyngitis
  • peripheral edema
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • taste disturbance
  • erythema
  • pruritus
  • urticaria
  • pancreatitis
  • urticaria
  • blisters
  • exfoliative skin lesions
  • severe and disabling arthralgia
  • cutaneous vasculitis
  • cholecystitis
  • dyspepsia
  • abdominal discomfort
  • gastrointestinal abnormalities
  • increased serum amylase
  • increased lipase
  • vesicular pemphigoid
  • myalgia
  • paresthesia
  • fever
  • edema
  • swelling of hands and feet
  • elevated creatine phosphokinase
  • increased AST
  • elevated C-reactive protein
  • increased myoglobin levels

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored tightly closed and sealed. Additionally, it should be kept in a cool place at or below 30 degrees Celsius to maintain efficacy.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.